Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Responsiveness and Validation Study of MFM-32 in SMA Patients Treated With Nusinersen: NusiMFM

NCT04602195 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT04602195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04602195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Responsiveness and Validation Study of MFM-32 in SMA Patients Treated With Nusinersen: NusiMFM
Lead sponsor
Hospices Civils de Lyon
Phase
Observational
Overall status
Completed
Start date
January 19, 2021
Completion date
November 10, 2023
Enrollment
33 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

spinal muscular atrophy